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A facile synthesis of 3-hydroxy-3-(triﬂuoromethyl)-1H-pyrrol-2(3H)-ones based on triﬂuoroacetic acid-
catalyzed condensationecyclization reactions of b-enamino esters and ethyl triﬂuoropyruvate is de-
scribed. These reactions afford a series of a-triﬂuoromethylated g-lactam compounds in good to excellent
yields under mild conditions. A preliminary trial of an asymmetric catalytic version with chiral BINOL-
derived phosphoric acid as enantioselective catalyst was conducted and showed promising enantiose-
lectivity of the desired product.
 2014 Elsevier Ltd. All rights reserved.1. Introduction
The efﬁcient and facile construction of promising heterocycles is
a continuing challenge for synthetic chemistry. Heterocyclic com-
pounds containing a triﬂuoromethyl group in particular have
emerged as attractive synthetic targets due to their applications in
various ﬁelds like pharmacy, medicine, agriculture, material sci-
ence, etc.1 Among them, 3-hydroxy-3-(triﬂuoromethyl)-1H-pyrrol-
2(3H)-ones 3 (Scheme 1) as one type of triﬂuoromethyl-containing
g-lactams are important N-heterocyclic compounds in organic
synthesis, due to the potential application of the heterocyclic
structure for the synthesis of a series of drug-likemolecules bearing
a triﬂuoromethylated quaternary carbon center,2 and the a-hy-
droxy-a-triﬂuoromethyl amide skeleton is frequently encountered
in many natural products and pharmaceuticals with signiﬁcant
biologically activities.3 In this context, the development of novel
and efﬁcient methods for the construction of 3-hydroxy-3-(tri-
ﬂuoromethyl)-1H-pyrrol-2(3H)-one structures is therefore highly
important and desirable. However, the synthetic approaches to the
3-hydroxy-3-(triﬂuoromethyl)-1H-pyrrol-2(3H)-one skeletons are@cioc.ac.cn, yuanweicheng@
All rights reserved.very rare.2,4 In continuation of our program on the synthesis of
various N-heterocyclic compounds,5 we have been interested in
exploring efﬁcient method for the synthesis of 3-hydroxy-3-(tri-
ﬂuoromethyl)-1H-pyrrol-2(3H)-ones. We envisioned that the re-
action between b-enamino esters 1 and ethyl triﬂuoropyruvate 2
with appropriate catalyst could provide rapid access to 3-hydroxy-Scheme 1. Design strategy for the synthesis of 3-hydroxy-3-(triﬂuoromethyl)-1H-
pyrrol-2(3H)-one compounds.
Table 2
Substrate scope for the tandem condensationecyclization reaction of N-protected b-
enamino esters and ethyl triﬂuoropyruvatea
Entry 1 3 Yieldb (%)
1
Q.-L. Pei et al. / Tetrahedron 70 (2014) 4595e460145963-(triﬂuoromethyl)-1H-pyrrol-2(3H)-one compounds via a tandem
condensationecyclization pathway (Scheme 1).
Actually, as a building block for generating triﬂuoromethylated
heterocycles, ethyl triﬂuoropyruvate is envisioned to be an ideal
candidate. There are many examples of nucleophilic addition to
ethyl triﬂuoropyruvate with various nucleophiles have been re-
ported.2,4,6 Indeed, each of the reported methods results in a dif-
ferent class of CF3-containing compounds that may play as
promising biologically active motifs for pharmaceuticals and ag-
rochemicals. However, there were very few examples found in the
literature on the application of b-enamino esters as nucleophiles
reacting with ethyl triﬂuoropyruvate,2,4 despite that b-enamino
esters have been utilized as versatile reagents that participate in
a wide range of organic reactions.7 Herein, we report the tri-
ﬂuoroacetic acid-catalyzed reactions between b-enamino esters
and ethyl triﬂuoropyruvate for the synthesis of functionalized 3-
hydroxy-3-(triﬂuoromethyl)-1H-pyrrol-2(3H)-ones via a tandem
condensationecyclization process.
2. Results and discussion
Our experiments began with the reaction of (Z)-methyl-3-
phenyl-3-(phenylamino)acrylate (1a) and ethyl triﬂuoropyruvate
(2). Reaction optimization involved variation of catalyst, solvent,
and catalyst loading and the results from these experiments were
shown in Table 1. We examined the model reaction in CH2Cl2 in the
presence of 10 mol % p-toluenesulfonic acid (TsOH) at room tem-
perature. After 8 h, a mixture of the desired con-
densationecyclization product 3a and condensation product 4a in
89:11 ratio was provided in 41% yield (Table 1, entry 1). However,
when themixture of 3a and 4awas dried under vacuum at 80 C for
10 h, 4a could be completely converted to 3a, giving the ﬁnal
product 3-hydroxy-3-(triﬂuoromethyl)-1H-pyrrol-2(3H)-one 3a in
41% yield for two steps (Table 1, entry 2). Among the Brønsted acids
that were screened, triﬂuoroacetic acid (TFA) gave the best resultTable 1
Optimization of the reaction conditionsa
Entry Solvent Catalyst Yieldb (%)
1 CH2Cl2 TsOH 41c
2 CH2Cl2 TsOH 41
3 CH2Cl2 AcOH 41
4 CH2Cl2 TFA 95
5 CH2Cl2 MeSO3H 77
6 CH2Cl2 PhCO2H 56
7 DCE TFA 73
8 Toluene TFA 90
9 CH3CN TFA 82
10 THF TFA Trace
11 DMF TFA Trace
12 DMSO TFA Trace
13 H2O TFA nr
14 CH2Cl2 TFA 83d
15 CH2Cl2 TFA 67e
a Unless otherwise noted, the reaction was ﬁrstly carried out with 1a (0.2 mmol),
2 (0.5 mmol), and catalyst (0.02 mmol) in solvent (2.0 mL) at room temperature for
8 h. The product was puriﬁed as a mixture of 3a and 4a via column chromatography
on silica gel, and then the mixture was dried under vacuum at 80

C for 10 h to
furnish the end product 3a.
b Isolated yield of 3a for two steps.
c Isolated yield of themixture of 3a and 4a and the ratio 89:11 was determined by
1H NMR analysis.
d TFA (5 mol %) was used.
e TFA (1 mol %) was used. TFA¼triﬂuoroacetic acid, DCE¼1,2-dichloroethane,
nr¼no reaction.(Table 1, entries 2e6). In the case of TFA, it was observed that the
expected condensationecyclization product 3a could be smoothly
obtained in 95% yield (Table 1, entry 4). We then evaluated the
effect of solvents, the survey of reaction media, such as DCE, tolu-
ene, CH3CN, and THF, revealed that the results could not be further
improved (Table 1, entries 7e10). Afterward, some polar solvents
(DMF, DMSO, and H2O) were investigated, unfortunately, almost no
product was obtained with DMF or DMSO as the reaction medium,
and the reaction did not occur in water (Table 1, entries 11e13).
Thus, the best result was achieved in CH2Cl2 (Table 1, entry 4).
Lowering the catalyst loading from 10 mol % to 5 mol % and 1 mol %
led to signiﬁcant decrease in chemical yield (Table 1, entries 14 and
15). Accordingly, these studies provided the optimal reaction con-
ditions described in Table 1, entry 4.
Having a reasonable set of reaction conditions in hand, we
evaluated the scope of the N-protected b-enamino esters and the
results were shown in Table 2. Firstly, for the b-aryl-N-PMP b-
enamino esters 1bek, it was observed that these substrates toler-
ated substitution at any position of the aromatic ring, and both
electron-withdrawing (1bef) and electron-donating (1geh) func-
tionalities were compatible. The expected 3-hydroxy-3-(tri-
ﬂuoromethyl)-1H-pyrrol-2(3H)-ones 3beh could be smoothly
obtained in high yields (Table 2, entries 1e7). In the case of the 2-1 R ¼4-FC6H4 (1b) 3b 94
2 R1¼4-BrC6H4 (1c) 3c 96
3 R1¼2-ClC6H4 (1d) 3d 96
4 R1¼3-ClC6H4 (1e) 3e 94
5 R1¼4-ClC6H4 (1f) 3f 95
6 R1¼4-MeC6H4 (1g) 3g 88
7 R1¼4-MeOC6H4 (1h) 3h 88
8 R1¼2-Naphthyl (1i) 3i 91
9 R1¼2-Thienyl (1j) 3j 86
10 R1¼Cyclohexyl (1k) 3k 90
11 R2¼4-FC6H4 (1l) 3l 92
12 R2¼4-BrC6H4 (1m) 3m 91
13 R2¼4-ClC6H4 (1n) 3n 88
14 R2¼4-MeC6H4 (1o) 3o 96
15 R2¼2-MeOC6H4 (1p) 3p 93
16 R2¼3-MeOC6H4 (1q) 3q 95
17 R2¼4-MeOC6H4 (1r) 3r 95
18 R2¼Bn (1s) 3s 86
19 R3¼Et (1t) 3t 96
20 R3¼iPr (1u) 3u 95
21 R3¼tBu (1v) 3v 98
a Unless otherwise noted, the reaction was ﬁrstly carried out with 1 (0.2 mmol), 2
(0.5 mmol), and TFA (0.02 mmol) in CH2Cl2 (2.0 mL) at room temperature for 8 h.
The product was puriﬁed as a mixture of the desired condensationecyclization
product 3 and the condensation product via column chromatography on silica gel
and then the mixture was dried under vacuum at 80

C for 10 h to furnish the ﬁnal
product 3.
b Isolated yield of 3 for two steps. PMP¼p-methoxyphenyl.
Scheme 2. Large scale experiment for the synthesis of 3r, the transformation of 3r to 5,
and the X-ray structure of 3r.
Q.-L. Pei et al. / Tetrahedron 70 (2014) 4595e4601 4597naphthyl derivative 1i, very high yield for the corresponding
product 3i was achieved as well (Table 2, entry 8). N-PMP b-
enamino ester bearing heteroaromatic b-substituent was also
suitable substrate as exempliﬁed by the preparation of 3j (Table 2,
entry 9). Notably, the less reactive aliphatic compound 1k also
proved to be a competent substrate in the tandem con-
densationecyclization reaction affording the product 3k in 90%
yield (Table 2, entry 10). Our subsequent efforts focused on the b-
phenyl-N-aryl b-enamino esters 1ler. Introduction of an electron-
withdrawing or electron-donating group at the benzene ring of
the N-aryl group did not signiﬁcantly affect the yield (Table 2, en-
tries 11e17). Diverse products 3ler could be smoothly obtained in
yields ranging from 88% to 96%. Nevertheless, switching the N-aryl
group to N-benzyl group was no deleterious to the reactivity and
furnished 3s in 86% yield (Table 2, entry 18). Ultimately, it was
found that the R3 group in the ester moiety had no obvious in-
ﬂuence on the reactivity of this reaction (Table 2, entries 19e21).
Remarkably, high to excellent yields were obtained for all sub-
strates above-evaluated, demonstrating the generality and ro-
bustness of the present catalytic system.
Subsequently, the method was further extended to N-un-
protected b-enamine ester substrates (Table 3). The electronic
property of substituents on the aryl ring of the substrates had no
obvious effect on the generation of the product. Substrates bearing
electron-donating or electron-withdrawing substituents on the
aromatic ring were all able to smoothly react with ethyl tri-
ﬂuoropyruvate, delivering the corresponding products (Table 3,
3xea0) in very high yields. Furthermore, the 2-naphthyl substrate
1b0 and 2-thienyl 1c0 could afford the corresponding products 3b0
and 3c0 in 68% and 90% yields, respectively. Overall, the results, il-
lustrated in Tables 2 and 3, not only demonstrate that there is good
substrate scope for the reaction of b-enamine esters with ethyl
triﬂuoropyruvate (2) using triﬂuoroacetic acid as catalyst, providing
access to a range of 3-hydroxy-3-(triﬂuoromethyl)-1H-pyrrol-
2(3H)-ones in high to excellent yields, but also show that the fea-
ture of N-protected or N-unprotected in the substrates has no
deleterious to the reactivity.Table 3
Substrate scope for the tandem condensationecyclization reaction of N-unprotected
b-enamino esters and ethyl triﬂuoropyruvatea
Scheme 3. A preliminary attempt on the catalytic asymmetric reaction of b-enamine
ester and ethyl triﬂuoropyruvate.To test the practicality of the current method for the synthesis of
3-hydroxy-3-(triﬂuoromethyl)-1H-pyrrol-2(3H)-ones, reaction of
compound 1r with ethyl triﬂuoropyruvate (2) was performed on
a large scale under the standard reaction conditions. The reaction
proceeded smoothly to provide 3r in high to 92% yield (Scheme 2a).
The structure of product 3r has been conﬁrmed by X-ray crystalstructure analysis (Scheme 2).8 Furthermore, the obtained 3-
hydroxy-3-(triﬂuoromethyl)-1H-pyrrol-2(3H)-one product 3r
could be transformed into the densely functionalized 3-hydroxy-3-
(triﬂuoromethyl)pyrrolidin-2-one 5 bymeans of reductionwith Pd/
C and hydrogen in 87% yield with 51:49 dr under mild conditions
(Scheme 2b).8We also tried to develop a catalytic asymmetric version for the
tandem condensationecyclization process. The reaction of b-en-
amine ester 1s and ethyl triﬂuoropyruvate (2) was selected as
a model to illustrate the possibility of the catalytic asymmetric
process (Scheme 3). Gratifyingly, in the presence of 20 mol % chiral
BINOL-derived phosphoric acid A,9 the expected tandem con-
densationecyclization process proceeded smoothly under the
standard reaction conditions, and afforded product 3s in 95% yield
with 59% ee.10 The absolute conﬁguration of 3swas not determined
at the moment and the exploration of more effective chiral
Brønsted acids is undergoing.3. Conclusion
In summary, we have developed a facile method for the syn-
thesis of 3-hydroxy-3-(triﬂuoromethyl)-1H-pyrrol-2(3H)-ones
with triﬂuoroacetic acid-catalyzed the reactions of b-enamino es-
ters and ethyl triﬂuoropyruvate. Using this protocol, a series of
functionalized a-triﬂuoromethylated g-lactam compounds are able
to be smoothly obtained in good to excellent yields via a tandem
condensationecyclization process. The potential utilities of the
protocol also had been demonstrated by a large scale experiment
and further transformation of the product. Additionally, a pre-
liminary trial of an asymmetric catalytic versionwith chiral BINOL-
derived phosphoric acid as enantioselective catalyst was conducted
and afforded the desired product in excellent yield with moderate
enantioselectivity.
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4.1. General
Reagents were purchased from commercial sources and were
used as received unless mentioned otherwise. Reactions were
monitored by TLC. 1H NMR and 13C NMR (300 and 75 MHz,
respectively) spectra were recorded in CDCl3. 1H NMR chemical
shifts are reported in parts per million (ppm) relative to tetrame-
thylsilane (TMS) with the solvent resonance employed as the
internal standard. Data are reported as follows: chemical shift,
multiplicity (s¼singlet, br s¼broad singlet, d¼doublet, t¼triplet,
q¼quartet, m¼multiplet), coupling constants (Hz) and integration.
13C NMR chemical shifts are reported in parts per million (ppm)
from tetramethylsilane (TMS) with the solvent resonance as the
internal standard. Melting points were recorded on a Buchi Melting
Point B-545.
4.2. General procedure for the synthesis of 3-hydroxy-3-(tri-
ﬂuoromethyl)-1H-pyrrol-2(3H)-ones
To a test tube equipped with a magnetic stirring bar were
sequentially added 1 (0.20 mmol), TFA solution (c¼0.01 M, 2 mL
CH2Cl2), and ethyl triﬂuoropyruvate (0.5 mmol). Then the mixture
was stirred for indicated time at room temperature. After com-
pletion of the reaction, as monitored by TLC, the solvent was
removed under reduced pressure, and the residue was subjected to
ﬂash chromatography on silica gel (petroleum ether/ethyl
acetate¼5:1) to give the mixture of the corresponding product.
After that the mixture was dried in vacuum at 100 C for 10 h to
afford the single product 3.
4.2.1. Methyl 4-hydroxy-5-oxo-1,2-diphenyl-4-(triﬂuoromethyl)-4,5-
dihydro-1H-pyrrole-3-carboxylate (3a). White solid, 95% yield; mp
126.5e128.0 C; 1H NMR (300 MHz, CDCl3) d 7.39e7.20 (m, 8H),
6.98e6.96 (m, 2H), 5.18 (br s, 1H), 3.65 (s, 3H); 13C NMR (75 MHz,
CDCl3) d 51.7, 76.4 (q, J¼38.3 Hz,1C), 103.7, 123.0 (q, J¼286.7 Hz,1C),
127.5, 127.6, 127.9, 128.5, 129.1, 129.2, 130.5, 132.7, 159.9, 163.6,
169.7; HRMS (ESI) calcd for C19H14F3NNaO4 [MþNa]þ: 400.0767,
found: 400.0750.
4.2.2. Methyl 2-(4-ﬂuorophenyl)-4-hydroxy-1-(4-methoxyphenyl)-
5-oxo-4-(triﬂuoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate
(3b). White solid, 94% yield;mp 155.3e157.1 C; 1HNMR (300MHz,
CDCl3) d 7.23e7.18 (m, 2H), 7.01e6.95 (m, 2H), 6.86 (d, J¼9.0 Hz, 2H),
6.76 (d, J¼9.0 Hz, 2H), 5.13 (s, 1H), 3.73 (s, 3H), 3.65 (s, 3H); 13C NMR
(75 MHz, CDCl3) d 51.8, 55.3, 76.6 (q, J31.3 Hz, 1C), 103.5, 114.4,
115.3 (d, J¼22.0 Hz,1C), 122.9 (q, J¼286.5 Hz, 1C), 123.6 (d, J¼3.5 Hz,
1C), 125.0, 128.8, 131.5 (d, J¼8.7 Hz, 1C), 159.3, 159.4, 163.4, 163.6
(d, J¼250.7 Hz, 1C), 170.0; HRMS (ESI) calcd for C20H15F4NNaO5
[MþNa]þ: 448.0779, found: 448.0770.
4.2.3. Methyl 2-(4-bromophenyl)-4-hydroxy-1-(4-methoxyphenyl)-
5-oxo-4-(triﬂuoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate
(3c). White solid, 96% yield; mp 154.1e155.7 C; 1H NMR
(300MHz, CDCl3) d 7.43 (d, J¼8.1 Hz, 2H), 7.08 (d, J¼8.1 Hz, 2H), 6.86
(d, J¼8.7 Hz, 2H), 6.76 (d, J¼8.7 Hz, 2H), 5.29 (br, 1H), 3.74 (s, 3H),
3.65 (s, 3H); 13C NMR (75 MHz, CDCl3) d 51.9, 55.3, 76.6 (q,
J¼31.2 Hz, 1C), 103.7, 114.5, 122.8 (q, J¼286.5 Hz, 1C), 124.8, 125.2,
126.5, 128.7, 130.7, 131.2, 159.1, 159.4, 163.3, 169.9; HRMS (ESI) calcd
for C20H15BrF3NNaO5 [MþNa]þ: 507.9978, found: 507.9964.
4.2.4. Methyl 2-(2-chlorophenyl)-4-hydroxy-1-(4-methoxyphenyl)-
5-oxo-4-(triﬂuoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate
(3d). White solid, 96% yield; mp 127.9e128.8 C; 1H NMR
(300 MHz, CDCl3) d 7.38e7.11 (m, 4H), 7.01e6.97 (m, 2H), 6.75(d, J¼8.4 Hz, 2H), 5.00e4.89 (br, 1H), 3.73 (s, 3H), 3.62 (s, 3H); 13C
NMR (75MHz, CDCl3) d 51.8, 51.9, 55.3, 76.5 (q, J¼31.5 Hz,1C), 105.3,
105.4, 114.3, 122.8 (q, J¼286.9 Hz, 0.5C), 122.9 (q, J¼286.3 Hz, 0.5C),
124.6, 124.7, 126.5, 126.6, 127.9, 128.2, 128.7, 129.4, 129.5, 130.5,
131.3, 131.4, 132.1, 133.1, 157.5, 157.9, 159.6, 162.8, 163.1, 170.0, 170.2;
HRMS (ESI) calcd for C20H15ClF3NNaO5 [MþNa]þ: 464.0483, found:
464.0489.
4.2.5. Methyl 2-(3-chlorophenyl)-4-hydroxy-1-(4-methoxyphenyl)-
5-oxo-4-(triﬂuoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate
(3e). Yellow solid, 94% yield; mp 126.8e127.9 C; 1H NMR
(300 MHz, CDCl3) d 7.33 (d, J¼7.8 Hz, 1H), 7.26e7.19 (m, 2H), 7.04
(d, J¼7.8 Hz, 1H), 6.88 (d, J¼9.0 Hz, 2H), 6.77 (d, J¼9.0 Hz, 2H), 5.09
(br s, 1H), 3.74 (s, 3H), 3.65 (s, 3H); 13C NMR (75 MHz, CDCl3) d 51.9,
55.4, 76.6 (q, J¼31.3 Hz, 1C), 104.0, 114.5, 122.8 (q, J¼286.6 Hz, 1C),
124.8, 127.2, 128.8, 129.3, 129.4, 130.6, 133.9, 158.5, 159.5, 163.2,
169.9; HRMS (ESI) calcd for C20H15ClF3NNaO5 [MþNa]þ: 464.0483,
found: 464.0479.
4.2.6. Methyl 2-(4-chlorophenyl)-4-hydroxy-1-(4-methoxyphenyl)-
5-oxo-4-(triﬂuoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate
(3f). Yellow solid, 95% yield; mp 134.1e135.8 C; 1H NMR
(300MHz, CDCl3) d 7.29 (d, J¼8.4 Hz, 2H), 7.16 (d, J¼8.4 Hz, 2H), 6.88
(d, J¼9.0 Hz, 2H), 6.79 (d, J¼9.0 Hz, 2H), 5.09 (s, 1H), 3.77 (s, 3H),
3.68 (s, 3H); 13C NMR (75 MHz, CDCl3) d 51.9, 55.4, 76.6
(q, J¼31.5 Hz,1C),103.7, 114.5, 122.9 (q, J¼286.6 Hz,1C),124.9,126.0,
128.3, 128.8, 130.6, 136.8, 159.0, 159.4, 163.3, 169.9; HRMS (ESI)
calcd for C20H15ClF3NaO5 [MþNa]þ: 464.0483, found: 464.0485.
4.2.7. Methyl 4-hydroxy-1-(4-methoxyphenyl)-5-oxo-2-(p-tolyl)-4-
(t r iﬂuoromethyl)-4 ,5-dihydro-1H-pyrrole-3-carboxylate
(3g). Colorless oil, 88% yield; 1H NMR (300 MHz, CDCl3) d 7.07
(s, 4H), 6.86 (d, J¼9.0 Hz, 2H), 6.75 (d, J¼9.0 Hz, 2H), 5.16 (br s, 1H),
3.73 (s, 3H), 3.64 (s, 3H), 2.31 (s, 3H); 13C NMR (75 MHz, CDCl3)
d 21.5, 51.7, 55.3, 76.6 (q, J¼31.3 Hz, 1C), 103.0, 114.3, 123.0
(q, J¼286.5 Hz, 1C), 124.5, 125.3, 128.5, 128.8, 129.1, 140.9, 159.2,
160.5, 163.7, 170.2; HRMS (ESI) calcd for C21H18F3NNaO5 [MþNa]þ:
444.1029, found: 444.1024.
4.2.8. Methyl 4-hydroxy-1,2-bis(4-methoxyphenyl)-5-oxo-4-(tri-
ﬂuoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate (3h). Colorless
oil, 88% yield; 1H NMR (300 MHz, CDCl3) d 7.13 (d, J¼8.7 Hz, 2H),
6.87 (d, J¼9.0 Hz, 2H), 6.77 (d, J¼8.7 Hz, 2H), 6.76 (d, J¼9.0 Hz, 2H),
5.19 (s, 1H), 3.78 (s, 3H), 3.74 (s, 3H), 3.66 (s, 3H); 13C NMR (75 MHz,
CDCl3) d 51.7, 55.2, 55.3, 76.7 (q, J¼31.2 Hz, 1C), 102.5, 113.2, 114.3,
119.3, 123.0 (q, J¼286.6 Hz, 1C), 125.4, 128.7, 131.2, 159.2, 160.2,
161.1, 163.7, 170.2; HRMS (ESI) calcd for C21H18F3NNaO6 [MþNa]þ:
460.0978, found: 460.0957.
4.2.9. Methyl 4-hydroxy-1-(4-methoxyphenyl)-2-(naphthalen-2-yl)-
5-oxo-4-(triﬂuoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate
(3i). Red solid, 91% yield; mp 138.7e140.1 C; 1H NMR (300 MHz,
CDCl3) d 7.82e7.79 (m, 3H), 7.74e7.71 (m, 1H), 7.57e7.49 (m, 2H),
7.20 (d, J¼8.4 Hz, 1H), 6.92 (d, J¼8.7 Hz, 2H), 6.69 (d, J¼8.7 Hz, 2H),
5.25 (br s, 1H), 3.66 (s, 3H), 3.59 (s, 3H); 13C NMR (75 MHz, CDCl3)
d 51.8, 55.2, 76.7 (q, J¼31.3 Hz,1C), 103.5,114.3, 123.0 (q, J¼286.3 Hz,
1C), 124.9, 125.2, 125.3, 126.8, 127.6, 127.7, 128.5, 128.7, 130.1, 131.9,
133.6, 159.2, 160.2, 163.7, 170.2; HRMS (ESI) calcd for
C24H18F3NNaO5 [MþNa]þ: 480.1029, found: 480.1032.
4.2.10. Methyl 4-hydroxy-5-oxo-1-phenyl-2-(thiophen-2-yl)-4-(tri-
ﬂuoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate (3j). White
solid, 86% yield; mp 138.3e138.9 C; 1H NMR (300 MHz, CDCl3)
d 7.49e7.47 (m, 1H), 7.26e7.25 (m, 1H), 6.99e6.94 (m, 3H), 6.82
(d, J¼9.0 Hz, 2H), 5.24 (s, 1H), 3.77 (s, 3H), 3.74 (s, 3H); 13C NMR
(75 MHz, CDCl3) d 51.9, 55.4, 76.6 (q, J¼31.2 Hz, 1C), 103.5, 114.5,
Q.-L. Pei et al. / Tetrahedron 70 (2014) 4595e4601 4599122.9 (q, J¼286.7 Hz, 1C), 125.3, 126.5, 126.6, 129.1, 131.2, 133.8,
153.1, 159.7, 163.5, 169.7; HRMS (ESI) calcd for C18H14F3NO5S
[MþNa]þ: 436.0437, found: 436.0425.
4.2.11. Methyl 2-cyclohexyl-4-hydroxy-1-(4-methoxyphenyl)-5-oxo-
4-(triﬂuoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate
(3k). Colorless oil, 90% yield; 1H NMR (300MHz, CDCl3) d 7.07 (br s,
2H), 6.98 (d, J¼9.0 Hz, 2H), 4.90 (s, 1H), 3.87 (s, 3H), 3.85 (s, 3H),
2.90 (br, 1H), 1.69e1.59 (m, 8H), 1.07e1.01 (m, 2H); 13C NMR
(75 MHz, CDCl3) d 25.2, 26.1, 28.1, 28.9, 38.3, 51.7, 55.5, 76.1
(q, J¼30.9 Hz,1C),101.6,114.9,123.0 (q, J¼286.8 Hz,1C),125.8,129.7,
160.4, 163.7, 168.1, 171.0; HRMS (ESI) calcd for C20H22F3NNaO5
[MþNa]þ: 436.1342, found: 436.1348.
4.2.12. Methyl 1-(4-ﬂuorophenyl)-4-hydroxy-5-oxo-2-phenyl-4-(tri-
fluoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate (3l). White
solid, 92% yield; mp 122.5e123.9 C; 1H NMR (300 MHz, CDCl3)
d7.40e7.26 (m,3H), 7.20e7.17 (m,2H), 6.95e6.92 (m, 4H), 5.19 (s,1H),
3.63 (s, 3H); 13C NMR (75 MHz, CDCl3) d 51.8, 76.7 (q, J¼31.3 Hz, 1C),
103.8, 116.2 (d, J¼22.9 Hz, 1C), 122.9 (q, J¼286.7 Hz, 1C), 127.4, 128.0,
128.6 (d, J¼3.4Hz,1C),129.1,129.4 (d, J¼13.5Hz,1C),130.7,159.5,161.9
(d, J¼248.0 Hz,1C),163.5,169.8; HRMS (ESI) calcd for C19H13F4NNaO4
[MþNa]þ: 418.0673, found: 418.0667.
4.2.13. Methyl 1-(4-bromophenyl)-4-hydroxy-5-oxo-2-phenyl-4-
(triﬂuoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate (3m). Light
yellow solid, 91% yield; mp 186.1e187.8 C; 1H NMR (300 MHz,
CDCl3) d 7.42e7.29 (m, 5H), 7.20e7.18 (m, 2H), 6.83 (d, J¼8.7 Hz,
2H), 5.17 (s, 1H), 3.64 (s, 3H); 13C NMR (75 MHz, CDCl3) d 51.9, 77.0
(q, J¼37.8 Hz, 1C), 104.1, 122.5, 122.9 (q, J¼286.6 Hz, 1C), 127.3, 128.1,
128.9,129.2,130.8,131.7, 132.3, 159.2, 163.5, 169.5; HRMS (ESI) calcd
for C19H13BrF3NNaO4 [MþNa]þ: 477.9872, found: 477.9858.
4.2.14. Methyl 1-(4-chlorophenyl)-4-hydroxy-5-oxo-2-phenyl-4-(tri-
ﬂuoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate (3n). Yellow
solid, 88% yield; mp 161.6e163.3 C; 1H NMR (300 MHz, CDCl3)
d 7.43e7.39 (m, 1H), 7.35e7.31 (m, 2H), 7.28e7.20 (m, 4H), 6.91 (d,
J¼8.7Hz,2H),5.19 (s,1H),3.66 (s, 3H); 13CNMR(75MHz,CDCl3) d51.9,
76.8 (q, J¼31.0 Hz, 1C), 103.9, 122.8 (q, J¼286.7 Hz, 1C), 127.3, 128.1,
128.7, 129.1, 129.3, 130.8, 131.1, 134.4, 159.3, 163.5, 169.6; HRMS (ESI)
calcd for C19H13ClF3NNaO4 [MþNa]þ: 434.0377, found: 434.0380.
4.2.15. Methyl 4-hydroxy-5-oxo-2-phenyl-1-(p-tolyl)-4-(tri-
ﬂuoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate (3o). White
solid, 96% yield; mp 160.8e161.7 C; 1H NMR (300 MHz, CDCl3)
d 7.35e7.25 (m, 3H), 7.21e7.18 (m, 2H), 7.03 (d, J¼8.1 Hz, 2H), 6.83
(d, J¼8.1 Hz, 2H), 5.16 (br s, 1H), 3.62 (s, 3H), 2.25 (s, 3H); 13C NMR
(75 MHz, CDCl3) d 21.0, 51.7, 76.7 (q, J¼31.1 Hz, 1C), 103.5, 123.0 (q,
J¼286.5 Hz, 1C), 127.3, 127.7, 127.8, 129.1, 129.7, 130.0, 130.4, 138.6,
160.1, 163.6, 169.9; HRMS (ESI) calcd for C20H16F3NNaO4 [MþNa]þ:
414.0924, found: 414.0924.
4.2.16. Methyl 4-hydroxy-1-(2-methoxyphenyl)-5-oxo-2-phenyl-4-
(tr i f luoromethyl)-4 ,5-dihydro-1H-pyrrole-3-carboxylate
(3p). Yellow solid, 93% yield; mp 160.1e161.4 C; 1H NMR
(300 MHz, DMSO-d6) d 7.79 (s, 0.4H), 7.60 (s, 0.6H), 7.30e7.23 (m,
4H), 7.18e7.16 (m, 2H), 7.11e7.08 (m,1H), 6.94e6.85 (m, 2H), 3.60 (s,
3H), 3.49 (s, 3H); 13C NMR (75 MHz, DMSO-d6) d 50.9, 55.6, 55.7,
76.6 (q, J¼30.8 Hz, 1C), 105.0, 105.3, 112.1, 112.2, 120.3, 120.5, 121.6,
121.7, 123.0 (q, J¼285.1 Hz, 0.5C), 123.2 (q, J¼286.1 Hz, 0.5C), 127.4,
127.5, 128.2, 128.3, 128.7, 128.8, 129.7, 129.8, 130.1, 130.2, 130.7,
130.9, 154.9, 155.0, 160.2, 160.4, 161.8, 161.9, 171.3, 171.9; HRMS (ESI)
calcd for C20H16F3NNaO5 [MþNa]þ: 430.0873, found: 430.0870.
4.2.17. Methyl 4-hydroxy-1-(3-methoxyphenyl)-5-oxo-2-phenyl-4-
(triﬂuoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate (3q). Whitesolid, 95% yield; mp 141.6e142.9 C; 1H NMR (300 MHz, CDCl3)
d 7.37e7.20 (m, 5H), 7.13e7.10 (m, 1H), 6.78e6.77 (m, 1H),
6.54e6.47 (m, 2H), 5.18 (s, 1H), 3.64 (s, 3H), 3.63 (s, 3H); 13C NMR
(75 MHz, CDCl3) d 51.8, 55.3, 76.8 (q, J¼31.5 Hz, 1C), 103.6, 113.1,
114.5,119.7, 122.9 (q, J¼286.5 Hz,1C),127.6,127.9,129.1, 129.7, 130.6,
133.6, 159.8, 163.5, 169.6; HRMS (ESI) calcd for C20H16F3NNaO5
[MþNa]þ: 430.0873, found: 430.0872.
4.2.18. Methyl 4-hydroxy-1-(4-methoxyphenyl)-5-oxo-2-phenyl-4-
(trifluoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate (3r). White
solid, 95% yield; mp 148.8e149.9 C; 1H NMR (300 MHz, CDCl3)
d 7.35e7.28 (m, 3H), 7.20e7.17 (m, 2H), 6.88e6.84 (m, 2H),
6.75e6.72 (m, 2H), 5.11 (s, 1H), 3.72 (s, 3H), 3.63 (s, 3H); 13C NMR
(75 MHz, CDCl3) d 51.6, 55.3, 76.7 (q, J¼31.3 Hz, 1C), 103.4, 114.3,
123.0 (q, J¼286.6 Hz, 1C), 125.2, 127.7, 127.8, 128.8, 129.1, 130.4,
159.3, 160.2, 163.6, 170.1; HRMS (ESI) calcd for C20H16F3NNaO5
[MþNa]þ: 430.0873, found: 430.0879.
4.2.19. Methyl 1-benzyl-4-hydroxy-5-oxo-2-phenyl-4-(tri-
ﬂuoromethyl)-4,5-dihydro-1H-pyrrole-3-carboxylate (3s). White
solid, 86% yield; mp 122.8e123.7 C; 1H NMR (300 MHz, CDCl3)
d 7.50e7.45 (m,1H), 7.40e7.35 (m, 2H), 7.20e7.15 (m, 3H), 7.11e7.09
(m, 2H), 6.80e6.77 (m, 2H), 4.97 (s, 1H), 4.71 (d, J¼15.3 Hz,1H), 4.40
(d, J¼15.3 Hz,1H), 3.54 (s, 3H); 13C NMR (75MHz, CDCl3) d 44.6, 51.5,
76.5 (q, J¼31.4 Hz, 1C), 104.2, 122.9 (q, J¼286.2 Hz, 1C), 127.2, 127.8,
127.9, 128.2, 128.5, 130.5, 135.3, 160.4, 163.3, 171.0; HRMS (ESI) calcd
for C20H16F3NNaO4 [MþNa]þ: 414.0924, found: 414.0903.
4.2.20. Ethyl 4-hydroxy-5-oxo-1,2-diphenyl-4-(triﬂuoromethyl)-4,5-
dihydro-1H-pyrrole-3-carboxylate (3t). White solid, 96% yield; mp
104.0e105.4 C; 1H NMR (300 MHz, CDCl3) d 7.37e7.19 (m, 8H),
6.98e6.95 (m, 2H), 5.31 (br s, 1H), 4.16e4.05 (m, 2H), 1.01
(t, J¼7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) d 13.6, 61.0, 76.9
(q, J¼39.9 Hz,1C),103.9,123.0 (q, J¼286.5 Hz,1C), 127.5, 127.7, 127.8,
128.5,129.1,129.2,130.4,132.6,159.6,163.3,169.8; HRMS (ESI) calcd
for C20H16F3NNaO4 [MþNa]þ: 414.0924, found: 414.0916.
4.2.21. iso-Propyl 4-hydroxy-5-oxo-1,2-diphenyl-4-(tri-
ﬂuoromethyl)-4, 5-dihydro-1H-pyrrole-3-carboxylate (3u). White
solid, 95% yield; mp 110.2e111.6 C; 1H NMR (300 MHz, CDCl3)
d 7.37e7.18 (m, 8H), 6.98e6.95 (m, 2H), 5.34 (s, 1H), 5.03e4.95
(m, 1H), 1.12 (d, J¼6.3 Hz, 3H), 0.94 (d, J¼6.3 Hz, 3H); 13C NMR
(75MHz, CDCl3) d 21.2, 21.6, 69.0, 76.9 (q, J¼31.7 Hz,1C),104.5,123.1
(q, J¼286.4 Hz, 1C), 127.6, 127.7, 128.0, 128.4, 129.0, 129.3, 130.3,
132.9, 159.2, 162.9, 169.7; HRMS (ESI) calcd for C21H18F3NNaO4
[MþNa]þ: 428.1080, found: 428.1088.
4.2.22. tert-Butyl 4-hydroxy-5-oxo-1,2-diphenyl-4-(triﬂuoromethyl)-
4,5-dihydro-1H-pyrrole-3-carboxylate (3v). White foam, 98% yield;
mp 126.4e127.8 C; 1H NMR (300 MHz, CDCl3) d 7.32e7.17 (m, 8H),
6.96e6.94 (m, 2H), 5.48 (br s, 1H),1.25 (s, 9H); 13C NMR (75 MHz,
CDCl3) d 27.8, 76.9 (q, J¼31.2 Hz, 1C), 82.8, 105.3, 123.1
(q, J¼286.4 Hz, 1C), 127.6, 127.8, 128.2, 128.4, 129.0, 129.2, 130.1,
132.9, 158.3, 163.0, 169.8; HRMS (ESI) calcd for C22H20F3NNaO4
[MþNa]þ: 442.1237, found: 442.1231.
4.2.23. Methyl 4-hydroxy-5-oxo-2-phenyl-4-(triﬂuoromethyl)-4,5-
dihydro-1H-pyrrole-3-carboxylate (3w). White solid, 81% yield;
mp 124.8e125.1 C; 1H NMR (300 MHz, CDCl3) d 8.19 (br s, 1H),
7.61e7.47 (m, 5H), 5.03 (s, 1H), 3.71 (s, 3H); 13C NMR (75 MHz,
CDCl3) d 51.8, 77.5 (q, J¼31.8 Hz,1C), 102.3, 122.8 (q, J¼286.4 Hz,1C),
125.0, 127.9, 128.6, 132.0, 156.4, 163.5, 171.1; HRMS (ESI) calcd for
C13H10F3NNaO4 [MþNa]þ: 324.0454, found: 324.0442.
4.2.24. Methyl 4-hydroxy-5-oxo-2-(p-tolyl)-4-(triﬂuoromethyl)-4,5-
dihydro-1H-pyrrole-3-carboxylate (3x). White solid, 80% yield; mp
Q.-L. Pei et al. / Tetrahedron 70 (2014) 4595e46014600168.0e169.1 C; 1H NMR (300 MHz, DMSO-d6) d 11.09 (br s, 1H),
7.41 (d, J¼8.1 Hz, 2H), 7.34 (s, 1H), 7.29 (d, J¼8.1 Hz, 2H), 3.52 (s, 3H),
2.37 (s, 3H); 13C NMR (75 MHz, DMSO-d6) d 21.1, 50.9, 77.3
(q, J¼30.4 Hz,1C),102.6,123.2 (q, J¼285.0 Hz,1C),126.0,128.7,141.2,
157.5, 162.6, 173.3; HRMS (ESI) calcd for C14H12F3NNaO4 [MþNa]þ:
338.0611, found: 338.0601.
4.2.25. Methyl 4-hydroxy-2-(4-methoxyphenyl)-5-oxo-4-(triﬂuoro
methyl)-4,5-dihydro-1H-pyrrole-3-carboxylate (3y). White solid,
93% yield; mp 165.5e167.0 C; 1HNMR (300MHz, DMSO-d6) d 11.04
(br s, 1H), 7.51 (d, J¼8.7 Hz, 2H), 7.27 (s, 1H), 7.03 (d, J¼8.7 Hz, 2H),
3.82 (s, 3H), 3.55 (s, 3H); 13C NMR (75 MHz, DMSO-d6) d 50.8, 55.5,
77.4 (q, J¼30.4 Hz, 1C), 101.8, 113.6, 120.8, 123.3 (q, J¼285.0 Hz, 1C),
130.7,157.2, 161.5,162.8,173.3; HRMS (ESI) calcd for C14H12F3NNaO5
[MþNa]þ: 354.0560, found: 354.0559.
4.2.26. Methyl 2-(4-bromophenyl)-4-hydroxy-5-oxo-4-(triﬂuoro
methyl)-4,5-dihydro-1H-pyrrole-3-carboxylate (3z). White solid,
84% yield; mp 180.1e181.2 C; 1H NMR (300MHz, DMSO-d6) d 11.21
(br s, 1H), 7.71 (d, J¼8.4 Hz, 2H), 7.46 (d, J¼8.4 Hz, 2H), 7.41 (s, 1H),
3.53 (s, 3H); 13C NMR (75 MHz, DMSO-d6) d 51.0, 77.3 (q, J¼30.5 Hz,
1C), 103.7, 123.1 (q, J¼284.9 Hz, 1C), 124.6, 128.2, 130.8, 131.3, 156.7,
162.3, 173.2; HRMS (ESI) calcd for C13H9BrF3NNaO4 [MþNa]þ:
401.9559, found: 401.9549.
4.2.27. Methyl 2-(2-chlorophenyl)-4-hydroxy-5-oxo-4-(triﬂuoro
methyl)-4,5-dihydro-1H-pyrrole-3-carboxylate (3a0). White solid,
94% yield; mp 133.7e135.0 C; 1H NMR (300MHz, DMSO-d6) d 11.13
(br s, 1H), 7.60e7.57 (m, 1H), 7.51e7.47 (m, 1H), 7.45e7.36 (m, 3H),
3.43 (s, 3H); 13C NMR (75 MHz, DMSO-d6) d 50.9, 76.8 (q, J¼30.8 Hz,
1C), 106.0, 123.1 (q, J¼285.1 Hz, 1C), 127.3, 129.5, 129.8, 131.4, 131.7,
156.0, 161.5, 173.2; HRMS (ESI) calcd for C13H9ClF3NNaO4 [MþNa]þ:
358.0064, found: 358.0061.
4.2.28. Methyl 4-hydroxy-2-(naphthalen-2-yl)-5-oxo-4-(triﬂuoro
methyl)-4,5-dihydro-1H-pyrrole-3-carboxylate (3b0). White solid,
68% yield; mp 109.1e110.8 C; 1H NMR (300MHz, DMSO-d6) d 11.25
(br s, 1H), 8.16 (s, 1H), 8.07e7.99 (m, 3H), 7.67e7.55 (m, 3H), 7.41 (br
s, 1H), 3.53 (s, 3H); 13C NMR (75 MHz, DMSO-d6) d 50.9, 77.4 (q,
J¼30.4 Hz, 1C), 103.5, 123.2 (q, J¼284.9 Hz, 1C), 125.6, 126.6, 126.9,
127.5, 127.7, 127.9, 128.7, 132.0, 133.8, 157.8, 162.5, 173.3; HRMS (ESI)
calcd for C17H12F3NNaO4 [MþNa]þ: 374.0611, found: 374.0600.
4.2.29. Methyl 4-hydroxy-5-oxo-2-(thiophen-2-yl)-4-(triﬂuoro
methyl)-4,5-dihydro-1H-pyrrole-3-carboxylate (3c0). White solid,
90% yield; mp 163.4e164.9 C; 1H NMR (300 MHz, DMSO-d6)
d 11.26 (br s, 1H), 8.03 (d, J¼5.1 Hz, 1H), 7.91e7.89 (m, 1H), 7.31 (s,
1H), 7.24 (t, J¼5.1 Hz,1H), 3.67 (s, 3H); 13C NMR (75MHz, DMSO-d6)
d 51.2, 77.2 (q, J¼30.4 Hz, 1C), 100.7, 123.2 (q, J¼285.2 Hz, 1C), 127.3,
128.6, 133.9, 134.9, 149.3, 163.1, 172.7; HRMS (ESI) calcd for
C11H8F3NNaO4S [MþNa]þ: 330.0018, found: 330.0009.
4.3. The procedure for the transformation of 3r to 5
A solution of 3r (1 mmol) in anhydrous methanol (30 mL) was
treated with palladium (20 wt % on charcoal) under a hydrogen
atmosphere. The reaction mixture was stirred for 12 h at room
temperature. After completion of the reaction, as determined by
TLC, the mixture was ﬁltered through Celite, concentrated, and the
residue was puriﬁed by column chromatography (EtOAc/
hexane¼5:1) to obtain 5.
4.3.1. Methyl 4-hydroxy-1-(4-methoxyphenyl)-5-oxo-2-phenyl-4-
(trifluoromethyl)pyrrolidine-3-carboxylate (5). White foam, 87%
yield; mp 71.5e72.8 C; 1H NMR (300 MHz, CDCl3) d 7.30e7.16
(m, 6H), 7.10e7.08 (m, 1H), 6.78e6.73 (m, 2H), 5.75 (d, J¼6.6 Hz,0.4H), 5.69 (d, J¼6.6 Hz, 0.6H), 5.08 (br s, 0.4H), 4.94 (br s, 0.6H),
3.78 (s, 1.7H), 3.72e3.70 (m, 3.4H), 3.45 (d, J¼6.6 Hz, 0.6H), 3.27
(s, 1.3H); 13C NMR (75MHz, CDCl3) d 51.7, 51.8. 53.0, 54.5, 55.2, 55.3,
61.9, 62.5, 76.6 (q, J¼31.3 Hz, 0.4C), 78.5 (q, J¼31.5 Hz, 0.6C), 113.9,
114.1, 122.6 (q, J¼282.6 Hz, 0.4C), 123.3 (q, J¼283.4 Hz, 0.6C), 124.6,
125.3, 126.8, 128.0, 128.1, 128.3, 128.5, 128.7, 129.1, 133.2, 137.5,
157.4, 157.9, 166.2, 166.4, 167.8, 168.3; HRMS (ESI) calcd for
C20H18F3NNaO5 [MþNa]þ: 432.1029, found: 432.1015.
4.4. Procedure for the catalytic asymmetric reaction of b-
enamine ester and ethyl triﬂuoropyruvate
To a test tube equipped with a magnetic stirring bar were se-
quentially added 1s (0.20 mmol), A (20 mol %), CH2Cl2 (2 mL), and 2
(0.5 mmol). The mixture was stirred at room temperature for 7 h,
concentrated, and the residue was subjected to ﬂash chromatog-
raphy on silica gel (petroleum ether/ethyl acetate¼5:1) to give the
mixture of the corresponding product. Then the mixture was dried
in vacuum at 100 C for 10 h to afford the chiral product 3s as
a white solid in 95% yield, 59% ee. [a]D20 2.6 (c 0.72, EtOH); chiral
HPLC condition: Daicel Chiralpak AD-H, hexanes/i-PrOH¼70:30,
ﬂow rate¼1.0 mL/min, UV¼254 nm, tR¼5.77 min (minor) and
tR¼6.35 min (major).
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